Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
- Кому может быть актуально
- Состояния в реестре: Friedreich Ataxia. Базовые параметры: от 12 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Австрия, Франция, Германия
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
The PROFA study is an international, multi-centric observational and validation study to assess the patient-reported, psychosocial and economic outcomes of patients with Friedreich Ataxia (FA). Eligible patients will be recruited from six study centers in Germany, Austria and France. Patients will complete a baseline assessment via face-to-face interviews at the study centers and multiple momentary follow-up assessments via a mobile-health app at home daily to monthly for six months. Study results will gain essential and in-depth insights into the daily life of patients with FA.
Подробное описание
There is a lack of knowledge about the patient-reported, psychosocial, and economic impact of Friedreich's Ataxia (FA). The few previous studies were based on small sample sizes and annual cross-sectional data, limiting the generalizability of the results.
Therefore, the PROFA study aims
1. to assess the acceptability, feasibility, and usability of a mobile-health app for the collection of longitudinal real-time data, 2. to determine healthcare costs from a societal perspective that includes informal care productivity losses, to assess associated factors and to analyze the impact of evidence-based treatment on costs, 3. to validate measures of health-related quality of life (HRQoL), to assess patients' HRQoL and its fluctuation over time and identify associated factors, 4. to develop, validate and evaluate a new measure of hearing and speech disabilities' impact on patients' psychosocial health, and 5. to evaluate interaction effects between HRQoL, psychosocial health and economic outcomes in patients with FA.
Thus, the PROFA study will gain a comprehensive understanding of the individual, societal, and economic burden of FA, identifying determinants of health and social life and efficient use of healthcare resources. This is crucial to improve the treatment, care, and everyday life of FA patients and their families.
This validation and observational study will recruit patients from six study centers (Germany, France, and Austria). The data assessment will be based on (i) a baseline assessment via interviews at the study centers and (ii) a subsequent remote momentary data assessment via a mobile-health app on a daily to monthly basis for six months, covering assessments of ataxia severity, HRQoL, psychosocial health, speech and hearing disabilities, health services utilization, and specific health events. Descriptive and multivariate statistics will be used to describe the impact of FA on the patient-reported HRQoL, psychosocial health and economic outcomes.
Первичные конечные точки
- Usability of the mobile-health app as a remote monitoring momentary data assessment tool [Срок оценки: Six months]
- Acceptability of the mobile-health app as a remote monitoring momentary data assessment tool [Срок оценки: Month 6]
- Total societal costs [Срок оценки: Six months]
- Health-related quality of life [Срок оценки: Month 1]
- Health-related quality of life [Срок оценки: Month 3]
- Health-related quality of life [Срок оценки: Month 5]
- Health-related quality of life [Срок оценки: Month 6]
- Psychosocial health due to communication handicaps caused by speech and hearing disabilities [Срок оценки: Month 1]
- Psychosocial health due to communication handicaps caused by speech and hearing disabilities [Срок оценки: Month 2]
- Psychosocial health due to communication handicaps caused by speech and hearing disabilities [Срок оценки: Month 3]
Критерии участия
Критерии включения
- FA confirmed by molecular genetic testing
- Ataxia severity of ≤30 points according to the Scale of the Assessment and Rating of Ataxia (SARA)
- Access to a smartphone or tablet and able to operate the device
- Older than 12 years
Критерии исключения
- Lack of ability to give consent
- Ataxia severity >30 according to the Scale of the Assessment and Rating of Ataxia (SARA)
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
Германия · 4 центра
- Department of Neurology, RWTH Aachen University — Aachen
- German Center for Neuro-degenerative Diseases (DZNE) — Bonn
- Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik — Münich
- Neurologische Klinik und Hertie-Institut für Klinische Hirnforschung, Universitätsklinik T — Tübingen
Австрия · 1 центр
- Klinik für Neurologie, Medizinische Universität Innsbruck — Innsbruck
Франция · 1 центр
- Paris Brain Institute — Paris
Публикации
- Buchholz M, Weber N, Borel S, Sayah S, Xie F, Schulz JB, Reetz K, Boesch S, Klopstock T, Karin I, Schols L, Grobe-Einsler M, Klockgether T, Davies EH, Schmeder M, Nadke A, Michalowsky B. Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): protocol of an observational study using momentary data assessments via mobile health app. BMJ Open. 2023 Aug PMID 37527887
Идентификаторы
NCT: NCT05943002 · GR026